DBV Technologies S.A. Company Profile (NASDAQ:DBVT)

About DBV Technologies S.A. (NASDAQ:DBVT)

DBV Technologies S.A. logoDBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic & Testing Substances Manufacturers
  • Sub-Industry: N/A
  • Symbol: NASDAQ:DBVT
  • CUSIP: N/A
  • Web: www.dbv-technologies.com
  • Market Cap: $2.37158 billion
  • Outstanding Shares: 46,000,000
Average Prices:
  • 50 Day Moving Avg: $44.94
  • 200 Day Moving Avg: $39.47
  • 52 Week Range: $31.87 - $50.57
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.19
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $11.41 million
  • Price / Sales: 193.80
  • Book Value: $4.66 per share
  • Price / Book: 10.32
  • EBITDA: ($163,340,000.00)
  • Debt-to-Equity Ratio: 0.02%
  • Current Ratio: 6.75%
  • Average Volume: 187,945 shs.
  • Beta: 1.5
  • Short Ratio: 3.18

Frequently Asked Questions for DBV Technologies S.A. (NASDAQ:DBVT)

What is DBV Technologies S.A.'s stock symbol?

DBV Technologies S.A. trades on the NASDAQ under the ticker symbol "DBVT."

How were DBV Technologies S.A.'s earnings last quarter?

DBV Technologies S.A. (NASDAQ:DBVT) released its quarterly earnings results on Thursday, March, 26th. The company reported ($0.79) earnings per share for the quarter, missing analysts' consensus estimates of ($0.44) by $0.35. View DBV Technologies S.A.'s Earnings History.

Where is DBV Technologies S.A.'s stock going? Where will DBV Technologies S.A.'s stock price be in 2017?

8 brokers have issued 12-month price objectives for DBV Technologies S.A.'s stock. Their forecasts range from $50.00 to $72.00. On average, they expect DBV Technologies S.A.'s share price to reach $57.67 in the next year. View Analyst Ratings for DBV Technologies S.A..

Are investors shorting DBV Technologies S.A.?

DBV Technologies S.A. saw a increase in short interest in September. As of September 15th, there was short interest totalling 803,462 shares, an increase of 37.9% from the August 31st total of 582,768 shares. Based on an average daily volume of 161,950 shares, the days-to-cover ratio is currently 5.0 days.

Who are some of DBV Technologies S.A.'s key competitors?

Who are DBV Technologies S.A.'s key executives?

DBV Technologies S.A.'s management team includes the folowing people:

  • Pierre-Henri Benhamou, Chairman of the Board, Chief Executive Officer
  • David Schilansky, Chief Operating Officer
  • Hugh A. Sampson M.D., Chief Scientific Officer
  • Lucie Mondoulet, Director of Research
  • Nathalie Donne, Director of Corporate Communication & Business Development
  • Veronique Foutel, Director of Strategic Marketing
  • Wence Agbotounou, Chief Clinical Trial Officer
  • Bertrand Dupont, Industrial Director
  • Pascale Ehouarn, Industrial Development and Production Director
  • Laurent Martin, Director of Regulatory Affairs

How do I buy DBV Technologies S.A. stock?

Shares of DBV Technologies S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DBV Technologies S.A.'s stock price today?

One share of DBV Technologies S.A. stock can currently be purchased for approximately $48.07.

MarketBeat Community Rating for DBV Technologies S.A. (NASDAQ DBVT)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  116 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about DBV Technologies S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for DBV Technologies S.A. (NASDAQ:DBVT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 8 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $57.67 (19.96% upside)
Consensus Price Target History for DBV Technologies S.A. (NASDAQ:DBVT)
Price Target History for DBV Technologies S.A. (NASDAQ:DBVT)
Analysts' Ratings History for DBV Technologies S.A. (NASDAQ:DBVT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/8/2017Deutsche Bank AGBoost Price Target$46.00 -> $56.00N/AView Rating Details
10/6/2017Morgan StanleyReiterated RatingOverweight$70.00 -> $72.00N/AView Rating Details
10/2/2017Citigroup Inc.Boost Price TargetBuy$43.00 -> $57.00HighView Rating Details
9/12/2017Jefferies Group LLCReiterated RatingBuy$51.00LowView Rating Details
8/25/2017Leerink SwannBoost Price TargetOutperform$54.00 -> $60.00LowView Rating Details
7/6/2017HC WainwrightReiterated RatingBuy$50.00MediumView Rating Details
3/16/2017Societe GeneraleUpgradeHold -> BuyMediumView Rating Details
2/17/2017NatixisUpgradeNeutral -> BuyN/AView Rating Details
9/26/2016JMP SecuritiesInitiated CoverageOutperform$47.00N/AView Rating Details
12/3/2015Barclays PLCInitiated CoveragePositive -> Overweight$58.00N/AView Rating Details
10/23/2015Bank of America CorporationInitiated CoverageBuy$48.00N/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for DBV Technologies S.A. (NASDAQ:DBVT)
Earnings by Quarter for DBV Technologies S.A. (NASDAQ:DBVT)
Earnings History by Quarter for DBV Technologies S.A. (NASDAQ DBVT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/26/2015($0.44)($0.79)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for DBV Technologies S.A. (NASDAQ:DBVT)
2017 EPS Consensus Estimate: ($4.00)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.91)($0.91)($0.91)
Q2 20171($1.00)($1.00)($1.00)
Q3 20171($1.04)($1.04)($1.04)
Q4 20171($1.05)($1.05)($1.05)
(Data provided by Zacks Investment Research)


Dividend History for DBV Technologies S.A. (NASDAQ:DBVT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for DBV Technologies S.A. (NASDAQ:DBVT)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for DBV Technologies S.A. (NASDAQ:DBVT)
Latest Headlines for DBV Technologies S.A. (NASDAQ:DBVT)
Loading headlines, please wait.



DBV Technologies S.A. (DBVT) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.